Part B International Price Index: MedPAC Urges Focus On Enhanced Vendor Role
Executive Summary
In comments on Medicare Part B International Pricing Index, Medicare Payment Advisory Commission notes concerns with international reference pricing and advises a stronger role for private sector vendors to generate savings.
You may also be interested in...
Part D Brand Discounts May Be More Useful In Catastrophic Phase, House Panel Told
Medicare Payment Advisory Commission executive director Mathews suggests at April 30 hearing that manufacturers should bear more “liability” for catastrophic coverage in Medicare Part D.
Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues
President Trump touts CMS proposal that would peg Part B prices to an international index in the hopes of lowering US costs; industry calls it foreign price controls and warns it will hinder access.
Part B Reforms: MedPAC Moving Forward With 'Drug Value Program' Proposal
Even under most ambitious timeline, new competitive-bidding approach would not start before 2022 – and that assumes Congress has appetite for the legislation with an already full plate of health care work to do. But new ideas in Part B are worth watching.